• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.使用闪烁接近测定法实时、高通量测量肽-MHC-I 解离。
J Immunol Methods. 2011 Nov 30;374(1-2):5-12. doi: 10.1016/j.jim.2010.10.012. Epub 2010 Oct 31.
2
The influence of exogenous peptide on beta2-microglobulin exchange in the HLA complex: analysis in real-time.外源性肽对HLA复合物中β2微球蛋白交换的影响:实时分析
Immunogenetics. 1998 Jul;48(2):98-107. doi: 10.1007/s002510050409.
3
Assembly and dissociation of human leukocyte antigen (HLA)-A2 studied by real-time fluorescence resonance energy transfer.通过实时荧光共振能量转移研究人类白细胞抗原(HLA)-A2的组装与解离。
Biochemistry. 2000 Sep 12;39(36):11163-9. doi: 10.1021/bi000763z.
4
The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound.β2-微球蛋白解离速率是衡量MHC I类异源三聚体稳定性的准确指标,且取决于所结合的肽段。
J Immunol. 1992 Sep 15;149(6):1896-904.
5
Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis.修饰的人β2-微球蛋白(去赖氨酸(58))对MHC I类重链的亲和力降低,并诱导一氧化氮产生和细胞凋亡。
Scand J Immunol. 2009 Mar;69(3):203-12. doi: 10.1111/j.1365-3083.2008.02213.x.
6
Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides.稳定的肽与II类主要组织相容性复合体分子的结合迅速,并且由与低亲和力肽的先前结合所形成的接受性构象决定。
J Immunol. 1999 Apr 1;162(7):4030-6.
7
Dimerization of soluble disulfide trap single-chain major histocompatibility complex class I molecules dependent on peptide binding affinity.可溶性二硫键陷阱单链主要组织相容性复合体 I 分子的二聚化依赖于肽结合亲和力。
Antioxid Redox Signal. 2011 Aug 1;15(3):635-44. doi: 10.1089/ars.2010.3691. Epub 2011 Apr 8.
8
Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.从大肠杆菌中分离出的肽与HLA - A2和HLA - B27的结合。HLA - A2和HLA - B27重链/β2 - 微球蛋白复合物的重建需要特定的肽。
J Biol Chem. 1992 Mar 15;267(8):5451-9.
9
Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.基于差示扫描荧光法对肽 - 主要组织相容性复合体的热稳定性和动力学稳定性的评估。
J Immunol Methods. 2016 May;432:95-101. doi: 10.1016/j.jim.2016.02.016. Epub 2016 Feb 18.
10
Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility.MHC 蛋白中的动态驱动别构作用:依赖肽的 I 类 MHC 全局柔性调节。
Front Immunol. 2019 May 3;10:966. doi: 10.3389/fimmu.2019.00966. eCollection 2019.

引用本文的文献

1
Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors.多层次方法检测治疗性 T 细胞受体的自身免疫交叉反应性。
Sci Adv. 2023 Jul 28;9(30):eadg9845. doi: 10.1126/sciadv.adg9845. Epub 2023 Jul 26.
2
Immunoinformatics: Predicting Peptide-MHC Binding.免疫信息学:预测肽-MHC结合
Annu Rev Biomed Data Sci. 2020 Jul;3:191-215. doi: 10.1146/annurev-biodatasci-021920-100259. Epub 2020 Apr 27.
3
Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8T cells.肽:HLA 复合物稳定性对鉴定 SARS-CoV-2 特异性 CD8T 细胞的影响。
Front Immunol. 2023 May 18;14:1151659. doi: 10.3389/fimmu.2023.1151659. eCollection 2023.
4
Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Infected Cells.感染细胞中BoLA-I和BoLA-DR呈递肽段的免疫肽组学分析
Vaccines (Basel). 2022 Nov 11;10(11):1907. doi: 10.3390/vaccines10111907.
5
Cancer vaccines: Building a bridge over troubled waters.癌症疫苗:在波涛汹涌的海面上架起桥梁。
Cell. 2022 Jul 21;185(15):2770-2788. doi: 10.1016/j.cell.2022.06.035. Epub 2022 Jul 13.
6
Opening opportunities for K determination and screening of MHC peptide complexes.为 MHC 肽复合物的 K 测定和筛选开辟机会。
Commun Biol. 2022 May 23;5(1):488. doi: 10.1038/s42003-022-03366-0.
7
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations.针对致癌 KRAS 突变的 T 细胞靶点的系统发现和验证。
Cell Rep Methods. 2021 Sep 16;1(5):100084. doi: 10.1016/j.crmeth.2021.100084. eCollection 2021 Sep 27.
8
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.突变 KRAS 表位的生化和功能特征使该癌蛋白成为免疫靶向治疗的有效靶点。
Nat Commun. 2021 Jul 16;12(1):4365. doi: 10.1038/s41467-021-24562-2.
9
Epitope prediction and identification- adaptive T cell responses in humans.表位预测和鉴定——人类适应性 T 细胞反应。
Semin Immunol. 2020 Aug;50:101418. doi: 10.1016/j.smim.2020.101418. Epub 2020 Oct 31.
10
A Systematic, Unbiased Mapping of CD8 and CD4 T Cell Epitopes in Yellow Fever Vaccinees.黄热病疫苗接种者中 CD8 和 CD4 T 细胞表位的系统、无偏映射。
Front Immunol. 2020 Aug 31;11:1836. doi: 10.3389/fimmu.2020.01836. eCollection 2020.

本文引用的文献

1
One-pot, mix-and-read peptide-MHC tetramers.一步法、混合即读型肽-MHC四聚体
PLoS One. 2008 Feb 27;3(2):e1678. doi: 10.1371/journal.pone.0001678.
2
A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.对痘苗病毒感染后所识别的T细胞特异性库影响因素的定量分析。
J Immunol. 2007 Jun 15;178(12):7890-901. doi: 10.4049/jimmunol.178.12.7890.
3
Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.一种与抑制剂高通量筛选兼容的人胰岛素样生长因子结合蛋白4闪烁邻近分析方法的开发。
Anal Biochem. 2007 Jul 1;366(1):80-6. doi: 10.1016/j.ab.2007.03.011. Epub 2007 Mar 18.
4
Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor.闪烁邻近分析法作为一种高通量方法,用于鉴定与促性腺激素释放激素(GnRH)受体结合的缓慢解离非肽配体。
J Biomol Screen. 2007 Mar;12(2):235-9. doi: 10.1177/1087057106297362. Epub 2007 Jan 4.
5
Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu.源自Her-2/neu的HLA-A*0201限制性T细胞表位中的二级锚定取代
Mol Immunol. 2007 Jan;44(4):322-31. doi: 10.1016/j.molimm.2006.02.027. Epub 2006 Apr 4.
6
Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.基于荧光偏振的 HLA-A*0201 竞争性肽结合测定法的开发与验证——一种新的表位发现工具
Biochemistry. 2005 Sep 20;44(37):12491-507. doi: 10.1021/bi050255v.
7
The immune epitope database and analysis resource: from vision to blueprint.免疫表位数据库与分析资源:从构想蓝图。 (此句英文表述不太完整流畅,推测完整意思并翻译,供你参考。更准确翻译需结合完整原文背景。)
PLoS Biol. 2005 Mar;3(3):e91. doi: 10.1371/journal.pbio.0030091.
8
Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.通过荧光偏振实时测量体外肽与可溶性HLA-A*0201的结合。
Biochemistry. 2004 Nov 23;43(46):14852-63. doi: 10.1021/bi048580q.
9
Preparation of iodine-131 labelled human growth hormone of high specific activity.高比活度碘-131标记人生长激素的制备
Nature. 1962 May 5;194:495-6. doi: 10.1038/194495a0.
10
Thermodynamic and kinetic analysis of a peptide-class I MHC interaction highlights the noncovalent nature and conformational dynamics of the class I heterotrimer.肽与I类主要组织相容性复合体相互作用的热力学和动力学分析突出了I类异源三聚体的非共价性质和构象动力学。
Biochemistry. 2003 May 6;42(17):4954-61. doi: 10.1021/bi034077m.

使用闪烁接近测定法实时、高通量测量肽-MHC-I 解离。

Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.

机构信息

Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Denmark.

出版信息

J Immunol Methods. 2011 Nov 30;374(1-2):5-12. doi: 10.1016/j.jim.2010.10.012. Epub 2010 Oct 31.

DOI:10.1016/j.jim.2010.10.012
PMID:21044632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4341823/
Abstract

Efficient presentation of peptide-MHC class I complexes to immune T cells depends upon stable peptide-MHC class I interactions. Theoretically, determining the rate of dissociation of a peptide-MHC class I complexes is straightforward; in practical terms, however, generating the accurate and closely timed data needed to determine the rate of dissociation is not simple. Ideally, one should use a homogenous assay involving an inexhaustible and label-free assay principle. Here, we present a homogenous, high-throughput peptide-MHC class I dissociation assay, which by and large fulfill these ideal requirements. To avoid labeling of the highly variable peptide, we labeled the invariant β2m and monitored its dissociation by a scintillation proximity assay, which has no separation steps and allows for real-time quantitative measurement of dissociation. Validating this work-around to create a virtually label-free assay, we showed that rates of peptide-MHC class I dissociation measured in this assay correlated well with rates of dissociation rates measured conventionally with labeled peptides. This assay can be used to measure the stability of any peptide-MHC class I combination, it is reproducible and it is well suited for high-throughput screening. To exemplify this, we screened a panel of 384 high-affinity peptides binding to the MHC class I molecule, HLA-A*02:01, and observed the rates of dissociation that ranged from 0.1h to 46h depending on the peptide used.

摘要

有效的将肽-MHC Ⅰ类复合物呈递给免疫 T 细胞依赖于稳定的肽-MHC Ⅰ类复合物相互作用。从理论上讲,确定肽-MHC Ⅰ类复合物的解离速率是直接的;然而,在实践中,产生准确且时间接近的用于确定解离速率的数据并不简单。理想情况下,人们应该使用涉及无穷无尽和无标记的分析原理的均相测定。在这里,我们提出了一种均相、高通量的肽-MHC Ⅰ类解离测定法,在很大程度上满足了这些理想要求。为了避免标记高度可变的肽,我们标记了不变的β2m,并通过闪烁接近测定法监测其解离,该测定法没有分离步骤,允许实时定量测量解离。为了验证这种创建实质上无标记测定法的方法,我们表明,在该测定法中测量的肽-MHC Ⅰ类解离速率与使用标记肽常规测量的解离速率很好地相关。该测定法可用于测量任何肽-MHC Ⅰ类组合的稳定性,它具有可重复性,非常适合高通量筛选。为了举例说明这一点,我们筛选了一组 384 种与 MHC Ⅰ类分子 HLA-A*02:01 结合的高亲和力肽,并观察到根据所用肽的不同,解离速率从 0.1h 到 46h 不等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/759555c33fc1/nihms254237f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/257498e43663/nihms254237f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/3943de6d7c2a/nihms254237f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/dc19e4d0b63b/nihms254237f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/759555c33fc1/nihms254237f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/257498e43663/nihms254237f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/3943de6d7c2a/nihms254237f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/dc19e4d0b63b/nihms254237f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f395/4341823/759555c33fc1/nihms254237f4.jpg